SCHEMBL5407310

SCHEMBL5407310

N=CN1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10374846 1.00
SCHEMBL3967086 1.00
Hydrochloric Acid SCHEMBL11406903 0.97
SCHEMBL1648618 0.96
SCHEMBL5403195 0.96
Iodide SCHEMBL18249294 0.93
SCHEMBL6187126 0.71
SCHEMBL10332690 0.71
SCHEMBL11165550 0.71
SCHEMBL2254566 0.69 CA1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7193081-B2 9-(2-(2,4-cis(S)-4-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphor-inan-2 -yl)methoxyethyl)adenine by coupling the dichloridate of 9-(2-phosphonyl- methoxyethyl- or propyl)adenine (PMEA)(PMPA) with a 1-(chlorophenyl) propylene-1,3-diol METABASIS THERAPEUTICS, INC. (US) 2007-03-20 US claimed
EP-0082113-A1 2-Aminobytyl-2-penem derivatives, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1983-06-22 EP disclosed